The Human Phenotype Ontology in 2017.

Nucleic Acids Res 2017 01 28;45(D1):D865-D876. Epub 2016 Nov 28.

The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA

Deep phenotyping has been defined as the precise and comprehensive analysis of phenotypic abnormalities in which the individual components of the phenotype are observed and described. The three components of the Human Phenotype Ontology (HPO; www.human-phenotype-ontology.org) project are the phenotype vocabulary, disease-phenotype annotations and the algorithms that operate on these. These components are being used for computational deep phenotyping and precision medicine as well as integration of clinical data into translational research. The HPO is being increasingly adopted as a standard for phenotypic abnormalities by diverse groups such as international rare disease organizations, registries, clinical labs, biomedical resources, and clinical software tools and will thereby contribute toward nascent efforts at global data exchange for identifying disease etiologies. This update article reviews the progress of the HPO project since the debut Nucleic Acids Research database article in 2014, including specific areas of expansion such as common (complex) disease, new algorithms for phenotype driven genomic discovery and diagnostics, integration of cross-species mapping efforts with the Mammalian Phenotype Ontology, an improved quality control pipeline, and the addition of patient-friendly terminology.

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw1039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210535PMC
January 2017
108 Reads
93 Citations
9.112 Impact Factor

Publication Analysis

Top Keywords

phenotype ontology
12
deep phenotyping
8
phenotypic abnormalities
8
human phenotype
8
phenotype
5
registries clinical
4
organizations registries
4
driven genomic
4
disease organizations
4
rare disease
4
labs biomedical
4
clinical software
4
algorithms phenotype
4
resources clinical
4
biomedical resources
4
international rare
4
phenotype driven
4
clinical labs
4
diverse groups
4
hpo increasingly
4

Similar Publications